 |
인쇄하기
취소
|
Government to face another high price of new leukemia drug
The government will likely in a dilemma to determine the price of Tasigna, another leukemia drug produced by Novartis, as its Korean affiliate has applied to the Health Insurance Review Agency for a price evaluation.
Novartis Korea is trying to get 35,000-39,000 won per pill. Now it is up to the government agency to moderate the figure.
The fact that the price of Sprycel may affect that o...
Novartis Korea is trying to get 35,000-39,000 won per pill. Now it is up to the government agency to moderate the figure.
The fact that the price of Sprycel may affect that o...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.